Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion 2023-06-19 08:16
Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer 2023-06-15 19:00
Telix Opens European Radiopharmaceutical Production Facility 2023-06-08 20:00
Telix to Present at Jefferies Healthcare Conference 2023-06-06 08:40
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study 2023-05-08 05:00
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites 2023-05-08 05:00
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide 2023-05-02 05:00
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller 2023-05-01 08:58
Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid 2023-04-27 06:50
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter 2023-04-17 18:15
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical 2023-04-17 06:38
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate 2023-04-11 05:00
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 20:28
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 08:28
Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU 2023-03-14 05:11
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU 2023-03-09 04:51
Telix 2022 Full Year Results: Revenue up 20x in first year of commercial sales, underpins transition to cash flow positive 2023-02-27 14:37
Detailed Results from Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented at ASCO GU 2023-02-20 07:10
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine 2023-02-15 04:51
1 4 5 6 7 8 9